Avidity Biosciences
127 hedge funds and large institutions have $872M invested in Avidity Biosciences in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
+12
Holders Change %
+10.43%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
43
Reduced
31
Closed
13
Calls
$2.31M
Puts
$24K
Net Calls
+$2.28M
Net Calls Change
-$1.18M
Top Buyers
| 1 |
CAC
1
Cowen and Company
New York
|
$61.9M |
| 2 |
APM
2
Avidity Partners Management
Dallas,
Texas
|
$42.5M |
| 3 |
3
Goldman Sachs
New York
|
$10.1M |
| 4 |
RI
4
RTW Investments
New York
|
$84.4M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$44.1M |
